Ten-Year Data Show Image-Guided Tumor Ablation Cures Small Kidney Cancers Without a Scalpel
A ten-year single-center study reports 94 percent primary efficacy and 100 percent cancer-specific survival at five years for image-guided ablation ...
A ten-year single-center study reports 94 percent primary efficacy and 100 percent cancer-specific survival at five years for image-guided ablation ...
A retrospective Chinese study finds that adding the PD-1 inhibitor tislelizumab to paclitaxel-carboplatin chemotherapy and bevacizumab significantly improves response rates, ...
A multicenter study of 167 lung cancer patients found that persistent emotional distress across neoadjuvant therapy and surgery was independently ...
In the ongoing battle against prostate cancer, particularly in its metastatic castration-sensitive form, an emerging conversation has transpired regarding the ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.